Investigating how specific proteins affect spleen development in fetal cells
Specificity of RPSA-dependent translational control in mouse and human fetal spleen cells
This study is looking at how a protein called RPSA affects the development of the spleen in people with Isolated Congenital Asplenia, a condition where the spleen is missing or not fully formed, to help us understand how this might impact their immune system.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10647605 on NIH RePORTER |
What this research studies
This research focuses on understanding ribosomopathies, which are disorders caused by genetic abnormalities affecting ribosome function. It specifically examines the role of the RPSA protein in the development of the spleen, particularly in patients with Isolated Congenital Asplenia (ICA), a condition where the spleen is absent or underdeveloped. By studying mouse and human fetal spleen cells, the research aims to uncover how deficiencies in RPSA impact spleen development and function, which is crucial for the immune response. The methodology includes generating specific cell models to analyze the effects of RPSA mutations on spleen cell development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Isolated Congenital Asplenia or those with genetic mutations affecting ribosome function.
Not a fit: Patients without congenital asplenia or those not affected by ribosomopathies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and potential treatments for congenital asplenia and related disorders.
How similar studies have performed: Previous research has shown promising results in understanding ribosomopathies, indicating that this approach may yield valuable insights.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Selleri, Licia — University of California, San Francisco
- Study coordinator: Selleri, Licia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.